Next Financial Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Next Financial Group’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$0	Hold	7	–	–	﹤0.01%	3058
2021 Q3	$0	Hold	7	–	–	﹤0.01%	2872
2021 Q2	$0	Buy	+7	New	+$261	﹤0.01%	2773
2017 Q4	–	Sell	-1	Closed	-$2K	–	1594
2017 Q3	$2K	Buy	+1	New	+$2.35K	﹤0.01%	1646
2017 Q2	–	Hold	0	–	-$1K	–	2011
2017 Q1	–	Hold	0	–	–	–	1843
2016 Q4	–	Hold	0	–	–	–	2337
2016 Q3	–	Hold	0	–	–	–	2330

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Next Financial Group's NBRV Position: Q4 2021 in Review

Next Financial Group held its Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) position steady in Q4 2021 at 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3058.

Next Financial Group first reported a position in NBRV in Q3 2017 and has held it in 4 quarters since. The position peaked at $2K in Q3 2017. 34 funds tracked by Wall St. Rank hold NBRV as of Q4 2021.

Next Financial Group held 7 shares of Nabriva Therapeutics plc Ordinary Shares Ireland worth $0 as of Q4 2021.
Next Financial Group left its Nabriva Therapeutics plc Ordinary Shares Ireland share count unchanged in Q4 2021.
Nabriva Therapeutics plc Ordinary Shares Ireland made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #3058 holding.
Next Financial Group first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2017 and has held it in 4 quarters since.
Next Financial Group's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $2K in Q3 2017.
34 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.